Clinical Trials and Research News Weekly Roundup | S2 E12

Mar 16, 2020 | Digital Media, Video, Weekly Roundup

Youtube TrialSite News Weekly Roundup
  • EpicentRx Receives FDA Clearance of IND for Adenovirus Program AIM-001.
  • Gates Foundation Places $100m into Battling COVID-19 Including University of Leuven Virologist.
  • Toronto’s AI-vendor Cyclica Inks Strategic Collaboration with Elite Chinese Academic Research Center targeting COVID-19.
  • Nationwide Children’s Hospital Submits Proposal to HHS to use Genetically Engineered NK Cells Targeting COVID-19.
  • Canada Federal Government Continues to Fund Coronavirus Vaccine Research.
  • Genentech’s Esbriet Granted Breakthrough Therapy Designation for Unclassifiable Interstitial Lung Disease.
  • Karyopharm Announces Xpovio (selinexor) Combo Treatment Meets Primary Endpoint in Phase 3 BOSTON Study for Multiple Myeloma.
  • City of Hope Launches Phase I CAR T Therapy Trial based on Scorpion Toxin.
  • UTSW & Univ of Chicago Researchers Study Reveals Gut Bacteria can Penetrate Tumors Aiding Cancer Therapy.
  • UT Health San Antonio at the Forefront of the Clinical Research as a Care Option Movement for Latino Population in Southwest.
  • The World’s First NASH Drug Approved in India: Zydus Cadila’s Saroglitazar.
  • CHU Bichat-Claude Bernard Investigators (France) Study Hidradenitis Suppurativa and Conclude a Food Intolerance & Gut Dysbiosis Link.
  • University of Alberta Spinoff DrugBank Profiles 13K Drug Entries & Seeks Investment.
  • $2.5m Infused into Western Australia National Imaging Facility Node for Improved Research & Patient Care.
  • Piedmont Atlanta Hospital is the Lead Enrolling Site for National Transplant Clinical Trials.
  • Boston’s Cure Rare Disease on the Cusp of CRISPR-based Personalized Treatment for type of Duchenne Muscular Dystrophy.
  • AMSSM’s Research Network Funds Research to Prepare for NIH-Funded Trial Centering on Achilles Tendinopathy.

CORONAVIRUS 00.31

LUNG DISEASE 03.01

CANCER 03.30

LIVER DISEASE 05.21

AUTOIMMUNE 05.43

CLINICAL TRIAL 06.14

0 Comments